New Ozempic-like pill cuts weight by 13 per cent

A new weight-loss drug's effects could rival the current injection-only medication.

- 

Weight-loss drugs like Ozempic and Wegovy are a hot topic, but new research suggests there could be a more effective alternative: Amycretin.

In the first human trial of Amycretin, its creator Novo Nordisk A/S (the pharmaceutical company behind Ozempic) recorded promising results. In fact, the trial found that people taking Amycretin lost an average of 13.1 per cent of their body weight over a period of 12 weeks.

But unlike Ozempic and Wegovy, which require injections, Amycretin comes in pill form.